scholarly journals Paediatric HIV treatment outcome in Lagos: The Nigerian Institute of Medical Research experience

2020 ◽  
Vol 3 (4) ◽  
Author(s):  
David AN ◽  
Salako AO ◽  
Gbaja-Biamila TA ◽  
Odubela OO ◽  
Opaneye BA ◽  
...  
AIDS Care ◽  
2013 ◽  
Vol 25 (6) ◽  
pp. 744-747 ◽  
Author(s):  
E.W. Kimani-Murage ◽  
L. Manderson ◽  
S.A. Norris ◽  
K. Kahn

Author(s):  
Graham S. Cooke ◽  
Kirsty E. Little ◽  
Ruth M. Bland ◽  
Hilary Thulare ◽  
Marie-Louise Newell

2014 ◽  
Vol 100 (6) ◽  
pp. 527-531 ◽  
Author(s):  
Kirsty Le Doare ◽  
N E Mackie ◽  
S Kaye ◽  
A Bamford ◽  
S Walters ◽  
...  

2013 ◽  
Vol 17 (10) ◽  
pp. e919-e924 ◽  
Author(s):  
Ralf Otto-Knapp ◽  
Claudia P. Cortes ◽  
Felipe Saavedra ◽  
Marcelo Wolff ◽  
Thomas Weitzel

2021 ◽  
Author(s):  
Jeffrey M Osgood ◽  
Jeffrey W Froude ◽  
Sherri P Daye ◽  
Oscar A Cabrera ◽  
Matthew R Scherer ◽  
...  

ABSTRACT Introduction At the start of the coronavirus disease 2019 (COVID-19) pandemic, Walter Reed Army Institute of Research (WRAIR) mobilized to rapidly conduct medical research to detect, prevent, and treat the disease in order to minimize the impact of the pandemic on the health and readiness of U.S. Forces. WRAIR’s major efforts included the development of the Department of Defense (DoD) COVID-19 vaccine candidate, researching novel drug therapies and monoclonal antibodies, refining and scaling-up diagnostic capabilities, evaluating the impact of viral diversity, assessing the behavioral health of Soldiers, supporting U.S. DoD operational forces overseas, and providing myriad assistance to allied nations. WRAIR personnel have also filled key roles within the whole of government response to the pandemic. WRAIR had to overcome major pandemic-related operational challenges in order to quickly execute a multimillion-dollar portfolio of COVID-19 research. Consequently, the organization learned lessons that could benefit other leaders of medical research organizations preparing for the next pandemic. Materials and Methods We identified lessons learned using a qualitative thematic analysis of 76 observation/recommendation pairs from across the organization. These lessons learned were organized under the Army’s four pillars of readiness (staffing, training, equipping, and leadership development). To this framework, we added organizing and leading to best capture our experiences within the context of pandemic response. Results The major lessons learned for organizing were: (1) the pandemic created a need to rapidly pivot to new scientific priorities; (2) necessary health and safety precautions disrupted the flow of normal science and put programs at risk of missing milestones; (3) relationships with partners and allies facilitated medical diplomacy and advancement of U.S. national military and economic goals; and (4) a successful response required interoperability within and across multiple organizations. For equipping: (1) existing infrastructure lacked sufficient capacity and technical capability to allow immediate countermeasure development; (2) critical supply chains were strained; and (3) critical information system function and capacity were suddenly insufficient under maximum remote work. For staffing and training: (1) successful telework required rapid shifts in management, engagement, and accountability methods; and (2) organizational policies and processes had to adapt quickly to support remote staffing. For leading and leadership development (1) engaged, hopeful, and empathetic leadership made a difference; and (2) the workforce benefitted from concerted leadership communication that created a shared understanding of shifting priorities as well as new processes and procedures. Conclusions An effective pandemic response requires comprehensive institutional preparedness that facilitates flexibility and surge capacity. The single most important action leaders of medical research organizations can take to prepare for the next pandemic is to develop a quick-reaction force that would activate under prespecified criteria to manage reprioritization of all science and support activities to address pandemic response priorities at the velocity of relevance.


2014 ◽  
Vol 2 (7) ◽  
pp. e395-e396 ◽  
Author(s):  
Lucie Cluver ◽  
Lorraine Sherr ◽  
Ashraf Grimwood ◽  
Linda Richter ◽  
B Ryan Phelps ◽  
...  

2012 ◽  
Vol 16 (3) ◽  
pp. 549-558 ◽  
Author(s):  
John R Koethe ◽  
Meridith Blevins ◽  
Claire Bosire ◽  
Christopher Nyirenda ◽  
Edmond K Kabagambe ◽  
...  

AbstractObjectiveLow BMI is a major risk factor for early mortality among HIV-infected persons starting antiretrovial therapy (ART) in sub-Saharan Africa and the common patient belief that antiretroviral medications produce distressing levels of hunger is a barrier to treatment adherence. We assessed relationships between appetite, dietary intake and treatment outcome 12 weeks after ART initiation among HIV-infected adults with advanced malnutrition and immunosuppression.DesignA prospective, observational cohort study. Dietary intake was assessed using a 24 h recall survey. The relationships of appetite, intake and treatment outcome were analysed using time-varying Cox models.SettingA public-sector HIV clinic in Lusaka, Zambia.SubjectsOne hundred and forty-two HIV-infected adults starting ART with BMI <16 kg/m2and/or CD4+lymphocyte count <50 cells/μl.ResultsMedian age, BMI and CD4+lymphocyte count were 32 years, 16 kg/m2and 34 cells/μl, respectively. Twenty-five participants (18 %) died before 12 weeks and another thirty-three (23 %) were lost to care. A 500 kJ/d higher energy intake at any time after ART initiation was associated with an approximate 16 % reduction in the hazard of death (adjusted hazard ratio = 0·84;P= 0·01), but the relative contribution of carbohydrate, protein or fat to total energy was not a significant predictor of outcome. Appetite normalized gradually among survivors and hunger was rarely reported.ConclusionsPoor early ART outcomes were strikingly high in a cohort of HIV-infected adults with advanced malnutrition and mortality was predicted by lower dietary intake. Intervention trials to promote post-ART intake in this population may benefit survival and are warranted.


PLoS ONE ◽  
2009 ◽  
Vol 4 (9) ◽  
Author(s):  
Graham S. Cooke ◽  
Kirsty E. Little ◽  
Ruth M. Bland ◽  
Hilary Thulare ◽  
Marie-Louise Newell

2011 ◽  
Vol 31 (3) ◽  
pp. 235-245 ◽  
Author(s):  
A Bagenda ◽  
L Barlow-Mosha ◽  
D Bagenda ◽  
R Sakwa ◽  
M G Fowler ◽  
...  

AIDS Care ◽  
2016 ◽  
Vol 28 (sup2) ◽  
pp. 153-160 ◽  
Author(s):  
Dick Chamla ◽  
Chukwuemeka Asadu ◽  
Ebun Adejuyigbe ◽  
Abiola Davies ◽  
Ebele Ugochukwu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document